Pharmacological issues of linezolid: an updated critical review.
about
Dose optimisation of antibiotics in children: application of pharmacokinetics/pharmacodynamics in paediatricsExpression Profile of Markers of Apoptosis, Injury and Oxidative Stress in Human Lung Epithelium Cells-A5449 Receiving Chronic Exposure of Potential Anti-Tubercular Drug-trans-Cyclohexane-1, 4-Diamine Derivative-"9u".Linezolid manifests a rapid and dramatic therapeutic effect for patients with life-threatening tuberculous meningitis.Variability of linezolid concentrations after standard dosing in critically ill patients: a prospective observational studyLinezolid for treatment of chronic extensively drug-resistant tuberculosis.Changes in chest CT findings of pulmonary tuberculosis after linezolid treatment.Therapeutic drug monitoring of antimicrobials.Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin.Pharmacokinetics of Tedizolid in Morbidly Obese and Covariate-Matched Nonobese Adults.Predictors of Inadequate Linezolid Concentrations after Standard Dosing in Critically Ill Patients.Rapid emergence of resistance to linezolid and mutator phenotypes in Staphylococcus aureus isolates from an adult cystic fibrosis patient.How to optimize drug delivery in renal replacement therapy.Mitochondrial optic neuropathies: our travels from bench to bedside and back again.Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review.Subtherapeutic linezolid concentrations in a patient with morbid obesity and methicillin-resistant Staphylococcus aureus pneumonia: case report and review of the literature.The anti-tuberculosis agents under development and the challenges ahead.Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones.Linezolid in the treatment of drug-resistant tuberculosis: the challenge of its narrow therapeutic index.Effects of continuous renal replacement therapy on linezolid pharmacokinetic/pharmacodynamics: a systematic reviewClinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients.Systematic Therapeutic Drug Monitoring for Linezolid: Variability and Clinical Impact.Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant Staphylococcus aureus in a renal transplant recipient with Fabry-Anderson disease.Weight-adjusted versus fixed dose of linezolid for Chinese healthy volunteers of higher and lower body weight: a Phase I pharmacokinetic and pharmacodynamic study.Optimization of linezolid therapy in the critically ill: the effect of adjusted infusion regimens.Use of linezolid in neonatal and pediatric inpatient facilities--results of a retrospective multicenter survey.Pharmacokinetics and pharmacodynamics of Linezolid in burn patientsLactic Acidosis and Thrombocytopenia Associated with Linezolid Therapy: A Case Report
P2860
Q26853629-28EA507F-5A38-4444-AADA-F1D9A4B5F717Q34221391-C845E895-0515-4977-8060-4FFA5EA2708DQ34299173-4487762D-B989-4CC9-AEC2-FA391FACB3B3Q34486095-61B32459-EB07-4527-BEF6-59BB8FFACEBDQ34644127-BC4392F8-EEDC-4A7A-A61C-2660F7649F60Q35059096-2CBBA63B-FF02-4239-ABFF-02166A4DE8CFQ35640430-7978152A-A314-4205-BE86-DFC8226AAD14Q35959546-3730C3D7-29A0-450B-A1C9-1F75027EC915Q37120010-A2D00E17-6D7E-4F50-81F0-CC83021045CBQ37203803-8620C985-E0F2-4404-8F1B-4FABD1A3D1C6Q37263761-42891897-58B8-4E1E-9FF8-3E40E07A79FFQ37868687-9CE30F54-EDE9-4246-8336-35BD86F6FD32Q38083877-878B8445-3218-4878-BE69-164A75752953Q38100704-DDCF150C-6AB1-4BBA-A40F-74EE94F76AB4Q38101836-AAB7A321-A6B3-4948-96BF-F23F5C91A288Q38106836-52B3DF9B-7614-4967-BB8C-03F9A323DA23Q38617197-B43AEC10-B726-4967-9AD4-F91DA60B05C6Q38777085-280431ED-0832-44E0-8D33-8D334FE5BA20Q38929509-0CB087C4-4C8F-4F2D-BBD1-DD26DCD6B861Q39013332-2F0C4C1C-1B64-4022-B3D0-F3148E955F4BQ39278957-4E711FA7-3E80-4393-BD64-06EEFDA16EF1Q40121784-5FC6D3EB-2EE3-45CD-B390-85FB3082C2C6Q41858729-50BF37C6-307C-49A7-934E-6C0BE05A1DBCQ45375548-DF2A0072-97D3-40A9-A07D-A23E304E3825Q47881654-69D95069-ED95-4B8E-8A8A-4946EEC52182Q51505589-C7A8143B-C506-4AD5-962F-1D37BDB71129Q58130938-982EF1A1-D792-4706-B62B-7876C777E68FQ58710014-7D62A1E3-727D-4DDC-ADA0-907D36D69E33
P2860
Pharmacological issues of linezolid: an updated critical review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacological issues of linezolid: an updated critical review.
@en
Pharmacological issues of linezolid: an updated critical review.
@nl
type
label
Pharmacological issues of linezolid: an updated critical review.
@en
Pharmacological issues of linezolid: an updated critical review.
@nl
prefLabel
Pharmacological issues of linezolid: an updated critical review.
@en
Pharmacological issues of linezolid: an updated critical review.
@nl
P2093
P2860
P1476
Pharmacological issues of linezolid: an updated critical review.
@en
P2093
Antonello Di Paolo
Emanuele Guidotti
Mario Del Tacca
Paolo Malacarne
Romano Danesi
P2860
P304
P356
10.2165/11319960-000000000-00000
P577
2010-07-01T00:00:00Z
P6179
1024443490